Clinical Therapeutic Effects of Topical Agents in Adult Patients with Human Immunodeficiency Virus-related Oral Mucosa Ulcers: A Protocol for Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2021 Feb 13

PMID 33578511

Authors

Xiuming Ding

Feihu Xu

Xiang Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The number of adult patients affected by the human immunodeficiency virus (HIV) still remains high, mainly in the developing countries. However, only a few affected patients fail to experience oral lesions in the course of their experience with the virus. In particular, oral mucosa ulcers detected among HIV patients may be severe, which depictions may inhibit oral functioning and change patients' quality of life. Thus, it can result in considerable morbidity among this group of patients. To this end, the present study aims to examine the topical agent's clinical therapeutic efficacy among adult patients suffering from HIV-related oral mucosa ulcers.

Methods: For the investigation, only randomized controlled trials on any topical agent used to treat adult patients with HIV oral mucosa ulcers are to be explored from different databases: PubMed, the Cochrane Library, PsycINFO, EMBASE, SCOPUS, Web of Science, China Biomedical Literature Database, China National Knowledge Infrastructure, VIP, and WanFang databases. All databases will be searched from their inceptions to October 2020. Additionally, 2 independent authors will evaluate the possibly eligible studies to be included in the study. They will also perform data's trial extraction and risk of bias assessment. Accordingly, all data will be analysed by means of the RevMan 5.3 software.

Results: The present study seeks to evaluate the topical agents' clinical therapeutic efficacy to treat adult patients with HIV-related oral mucosa ulcers.

Conclusion: The study can be applicable in providing evidence of any topical agents for treating adult patients with HIV-related oral mucosa ulcers for clinical practice.

Protocol Registration Number: DOI 10.17605/OSF.IO/5CYR2 (https://osf.io/5cyr2/).

References

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

Kerr A, Ship J . Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol. 2003; 4(10):669-80. DOI: 10.2165/00128071-200304100-00002. View

DerSimonian R, Laird N . Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015; 45(Pt A):139-45. PMC: 4639420. DOI: 10.1016/j.cct.2015.09.002. View

Klatzmann D, Barre-Sinoussi F, Nugeyre M, Danquet C, Vilmer E, Griscelli C . Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984; 225(4657):59-63. DOI: 10.1126/science.6328660. View

Barre-Sinoussi F, Chermann J, Rey F, Nugeyre M, Chamaret S, Gruest J . Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. Rev Invest Clin. 2004; 56(2):126-9. View

Vieira J, Frank E, Spira T, Landesman S . Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med. 1983; 308(3):125-9. DOI: 10.1056/NEJM198301203080303. View

Gottlieb M, Schroff R, Schanker H, Weisman J, Fan P, Wolf R . Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981; 305(24):1425-31. DOI: 10.1056/NEJM198112103052401. View

Small C, Klein R, Friedland G, Moll B, Emeson E, SPIGLAND I . Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med. 1983; 74(3):433-41. DOI: 10.1016/0002-9343(83)90970-1. View

Coakley E, Samore M, Gillis J, Hughes M, Hammer S . The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l. AIDS. 2000; 14(9):1147-53. DOI: 10.1097/00002030-200006160-00011. View

10.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

11.

Masur H, Ognibene F, Yarchoan R, Shelhamer J, Baird B, Travis W . CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989; 111(3):223-31. DOI: 10.7326/0003-4819-111-3-223. View

12.

Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T . T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984; 312(5996):767-8. DOI: 10.1038/312767a0. View

13.

Gallo R, Salahuddin S, Popovic M, Shearer G, Kaplan M, Haynes B . Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984; 224(4648):500-3. DOI: 10.1126/science.6200936. View